(GGAA)<sub>3</sub>-Based TF-PROTACs Enable Targeted Degradation of ETV6 to Inhibit Ewing Sarcoma Growth

Z Zhichuan Zhu (Lineberger Comprehensive Cancer Center) H He Chen (Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute) X Xing Qiu (Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute) H H. Umit Kaniskan (Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute) L Ling Xie X Xian Chen J Jian Jin P Pengda Liu

Article Details

Volume / Issue Vol. 147, Issue 16
Published April 23, 2025
Pages 13396-13404
ISSN 0002-7863
Publisher American Chemical Society

Journal Info

Journal of the American Chemical Society

American Chemical Society

ISSN: 0002-7863 Physical Sciences

Authors (8)

Z

Zhichuan Zhu

Lineberger Comprehensive Cancer Center

H

He Chen

Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute

X

Xing Qiu

Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute

H

H. Umit Kaniskan

Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute

L

Ling Xie

X

Xian Chen

J

Jian Jin

P

Pengda Liu